Sort   by:  
 Page size 
UnknownModified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Not available
S-EPMC9522585 | biostudies-literature
UnknownThe addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Not available
S-EPMC11147755 | biostudies-literature
Sort   by:  
 Page size